Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA (vonoprazan) Tablets through May 3, 2032
FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc.…
Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
Company announcement no. 7/2025 In accordance with Article 19 (3) of the…
ESOC 2025: Combined oral contraceptives triple risk of cryptogenic stroke in young women, new study shows
HELSINKI, May 20, 2025 /PRNewswire/ -- New research presented today at the…
Global Alzheimers Platform Foundation ApplaudsFDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimers Disease
WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation®…
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
April 25, 2025 13:17 ET | Source: Pyxis Oncology Gene signatures associated…
Q&A: Understanding the Carbon Footprint Methodology for the Olympic Games
22 April 2025 - The Olympic Games bring together athletes and spectators from…
Agoda and Atlys Unveil Co-Branded Advertising Campaign to Inspire Confidence in International Travel for Indian Travellers
NEW DELHI, April 16, 2025 /PRNewswire/ -- Digital travel platform Agoda and…
Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk
--Data presented at the American College of Cardiology Annual Scientific Session show…
Woodside to Divest Greater Angostura Assets to Perenco
HOUSTON--(BUSINESS WIRE)--Woodside has entered into an agreement with Perenco to divest its…
Nexdigm Enters the Next Paradigm of its Growth
Nexdigm is moving to the next chapter of its growth with the…
